This site is intended for healthcare professionals only
LoginRegister
Insufficient Efficacy, Safety Data: CDSCO Panel Rejects Zydus Phase III CT Waiver Request for VoclosporinZydus Usnoflast gets USFDA Orphan Drug Designation for amyotrophic lateral sclerosis
Child Given Wrong Injection at Government HospitalPiramal Critical Care launches Chlorpromazine Hydrochloride for Injection in US
Emcure Pharma inaugurates RnD centre in GujaratEmcure Pharma inaugurates RnD centre in Gujarat
Last Chance: PCI Extends Deadline for 2025-26 Academic Year ApprovalsLast Chance: PCI Extends Deadline for 2025-26 Academic Year Approvals
Sanofi gets USFDA fast track designation for neovascular age-related macular degeneration gene therapySanofi Healthcare India gets CDSCO Panel nod to study Nirsevimab
AstraZeneca Gets SEC Approval to Conduct Phase IV Trial of Hyperkalemia Drug Sodium Zirconium CyclosilicateCDSCO Panel Approves AstraZeneca's Protocol Amendment Proposal for Anti-cancer Drug Volrustomig...
Glenmarks Telma Surpasses Rs 1,000 Crore Revenue, Recognized in Harvard Case StudyGlenmark Life Sciences rebrands as Alivus Life Sciences
Aurobindo Pharma merges Pharmacin BV, Agile Pharma BVCCI approves merger of nine pharma entities with Sequent Scientific
JnJ seeks indication extension of Akeega from EMA for adults with metastatic hormone-sensitive prostate cancer, HRR gene alterationsJnJ Spravato gets USFDA nod as monotherapy for adults with treatment-resistant depression
Delhi HC Refuses to Lift Ban on Medipol Pharma After Substandard Clarithromycin, Noscapine Supplied to Armed ForcesMacleods Pharma Wins Legal Battle Over Linagliptin Patent
Roquette seeks CCI nod for IFF Pharma solutions biz acquisitionRoquette seeks CCI nod for IFF Pharma solutions biz acquisition
GSK Blenrep combos receive positive EMA Committee opinion in relapsed/refractory multiple myelomaGSK gets European Commission nod for expanded use of Jemperli in endometrial cancer
X